Importantly, the target genes from both signatures are involved in cancer-related processes such as cell cycle, apoptosis, p53 and DNA damage pathways, ErbB signaling, and cellular migration, providing functional insights that support the observed diagnostic and prognostic performance of our miRNA panels and confirming the selection criteria of our analytical strategy. The gene discussed is EGFR; the disease is cancer.